0001578563-24-000185.txt : 20240403
0001578563-24-000185.hdr.sgml : 20240403
20240403160756
ACCESSION NUMBER: 0001578563-24-000185
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240328
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Truex Samantha
CENTRAL INDEX KEY: 0002017156
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 24818747
MAIL ADDRESS:
STREET 1: C/O AVALO THERAPEUTICS, INC.
STREET 2: 540 GAITHER ROAD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2024-03-28
1
0001534120
Avalo Therapeutics, Inc.
AVTX
0002017156
Truex Samantha
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
0
0
0
/s/ Donald R. Reynolds by power of attorney
2024-04-03
EX-24
2
poastruex.txt
POASTRUEX
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby
constitutes and appoints each of Christopher Sullivan,
Jennifer Zoltoski, Donald R. Reynolds and Andrew J. Gibbons,
and each of them acting alone, signing singly, the
undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer, director and/or 10% or more
stockholder of Avalo Therapeutics, Inc. (the "Company"), Forms ID,
3, 4 and 5, Update Passphrase Acknowledgement (and any
amendments thereto) in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "1934 Act") and
Schedules 13D and/or Schedules 13G (and any amendment thereto)
in accordance with the 1934 Act, and the rules promulgated
thereunder;
(2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete
and execute any such Form ID, 3, 4 and 5, Update Passphrase
Acknowledgement and Schedules 13D and/or Schedules 13G (and
any amendments thereto) and to file timely such form with the
United States Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever in connection
with the foregoing which in the opinion of such attorney-in-
fact, may be of benefit to, in the best interest of, or
legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-
fact full power and authority to do and perform any and every
act and thing whatsoever requisite, necessary or proper to be
done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and
confirming that all such attorneys-in-fact, or such attorneys-
in-facts' substitute or substitutes, shall lawfully do or
cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such
capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the 1934 Act.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms
ID, 3, 4 and 5 and Schedules 13D and Schedules 13G
with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier
revoked by the undersigned, in a signed writing delivered to each
of the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 25th day of March 2024.
/s/ Samantha Truex
Printed Name: Samantha Truex